Are Medical Stocks Lagging Aurinia Pharmaceuticals (AUPH) This Year?

Company Performance - Aurinia Pharmaceuticals (AUPH) has returned approximately 72.9% since the beginning of the calendar year, significantly outperforming the average return of 3.9% for Medical companies [4] - The Zacks Consensus Estimate for AUPH's full-year earnings has increased by 20.3% over the past 90 days, indicating improved analyst sentiment and a stronger earnings outlook [3] Industry Comparison - Aurinia Pharmaceuticals is part of the Medical - Drugs industry, which includes 146 individual stocks and currently ranks 84 in the Zacks Industry Rank. The average gain for stocks in this group is 5% year-to-date, highlighting AUPH's superior performance [5] - In contrast, Cardinal Health, which belongs to the Medical - Dental Supplies industry, has returned 67.4% year-to-date, while its industry ranks 99 and has moved up by 9.1% [6]